CytexOrtho, formerly known as Cytex Therapeutics, Inc, is a cutting-edge medical technology company based in Durham, NC. They are focused on developing innovative solutions for the treatment of osteoarthritis (OA), particularly in the hip joint. With a mission to provide alternatives to hip replacement surgery, CytexOrtho is dedicated to advancing cartilage resurfacing technology to address the needs of younger patients suffering from early OA. Their breakthrough hip cartilage repair technology has received a Breakthrough Device Designation from the FDA, highlighting its potential to revolutionize the field of orthopedics.
Driven by a team of experts and innovators, CytexOrtho aims to tap into the growing hip preservation market, which is worth billions of dollars. Their future technologies, currently in development, hold the promise of transforming the lives of individuals affected by OA. However, it is important to note that these innovations are not yet approved by the FDA and are not commercially available. The company's progress toward clinical trials and their successful crowdfunding raise demonstrate their commitment to bringing their potential solutions to the market, pending regulatory approval.
Generated from the website